P&K Skin Research Center KRX:347740KOSDAQ
피엔케이피부임상연구센타 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, P&K Skin Research Center reported revenue of ₩6.6bn, up 20.1% year on year, and operating profit of ₩1.5bn. P&K Skin Research Center (피엔케이피부임상연구센타) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Op. margin 20%+ Dividend grower Screener
P&K Skin Research Center quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩6.6bn | +20.1% | ₩1.5bn margin 22.9% | ₩1.5bn |
| Q1 2026 | ₩6.2bn | -3.4% | ₩959m margin 15.4% | ₩1.5bn |
| Q4 2025 derived | ₩5.8bn | +12.7% | ₩752m margin 13.0% | −₩906m |
| Q3 2025 | ₩5.1bn | +7.1% | ₩452m margin 8.9% | ₩1.6bn |
| Q2 2025 | ₩5.5bn | +43.8% | ₩825m margin 15.0% | ₩1.6bn |
| Q1 2025 | ₩6.5bn | +54.3% | ₩1.9bn margin 29.6% | ₩2.3bn |
| Q4 2024 derived | ₩5.1bn | +3.6% | ₩739m margin 14.4% | ₩1.1bn |
| Q3 2024 | ₩4.7bn | +41.7% | ₩731m margin 15.5% | ₩2.3bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
P&K Skin Research Center top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest P&K Skin Research Center news Korean headlines
No articles yet.